Select Medical Holdings Corporation SEM R2K

Healthcare · Medical Care Facilities · United States

https://www.selectmedical.com

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics in the United States. The Critical Illness Recovery Hospital segment consists of hospitals that provide services for heart failure, infectious disease, respiratory failure and pulmonary disease, surgery requiring prolonged recovery, renal disease, neurological events, and trauma. The Rehabilitation Hospital segment offers therapy and rehabilitation treatments, including rehabilitative services for brain and spinal cord injuries, strokes, amputations, neurological disorders, orthopedic conditions, pediatric congenital or acquired disabilities, and cancer. The Outpatient Rehabilitation segment operates rehabilitation clinics that provide physical, occupational, and speech rehabilitation programs and services; and specialized programs, such as functional programs for work related injuries, hand therapy, pelvic health rehabilitation, post-concussion rehabilitation, pediatric and cancer rehabilitation, and athletic training services. Select Medical Holdings Corporation was founded in 1996 and is headquartered in Mechanicsburg, Pennsylvania.

Market & Price

Market Cap

$2.05B

Current Price

$16.50

High / Low (52W)

$16.54 / $11.56

Beta

0.80

Valuation

Stock P/E

15.42

Industry PE

23.65

Forward P/E

12.03

PEG Ratio

2.26

Book Value

$13.75

Price to Book

1.20

P/S

0.37

EV/EBITDA

11.53

Dividend Yield

1.52%

Profitability & Returns

ROCE

8.03%

ROE

9.81%

ROA

3.43%

Profit Margin

2.42%

Op Margin

6.92%

EPS (Latest Qtr)

$0.35

EPS (TTM)

$1.07

Balance Sheet & Liquidity

Debt/Equity

1.42

Quick Ratio

1.00

Current Ratio

1.15

Debt

$2.99B

Total Assets

$5.85B

Current Assets

$1.03B

Working Capital

$40.79M

Ownership

Promoter Holding

16.36%

Chg in Prom Hold

FII / Inst Holding

82.65%

Chg in FII Hold

Financial Snapshot

Enterprise Value

$5.36B

Total Revenue (TTM)

$5.52B

EBITDA

$465.00M

Free Cash Flow

$40.70M

Operating Cash Flow

$387.78M

Shares Outstanding

124.01M

Gross Margin

16.68%

Payout Ratio

23.36%

Growth (CAGR)

Revenue 5Y

5.76%

Profit 5Y

-2.75%

Revenue (YoY)

5.00%

Earnings (YoY)

-19.40%

PROS

Generates positive free cash flow.
In a confirmed uptrend (50-DMA above 200-DMA).

CONS

Earnings shrank at -2.8% CAGR over 5 years.

* The pros and cons are auto-generated from financial metrics.

Price Chart

Robinhood TradingView StockAnalysis

Fundamental Growth

Period: Metric:

Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).

Peer comparison

Peer companies in the same sector (Healthcare).

#	Name	CMP $	P/E	Mkt Cap	Div Yld %	ROCE %	ROE %	Rev CAGR 5Y %	Profit CAGR 5Y %
1	SEM Select Medical Holdings Corporation R2K	16.50	15.42	$2.05B	1.52%	8.03%	9.81%	5.76%	-2.75%
2	LLY Eli Lilly and Company SPX	1,105.00	39.21	$985.37B	0.63%	38.44%	107.46%	31.69%	48.96%
3	JNJ Johnson & Johnson SPX	225.33	26.11	$542.42B	2.38%	23.13%	26.42%	5.60%	14.32%
4	UNH UnitedHealth Group Incorporated SPX	380.31	28.66	$345.38B	2.32%	9.60%	12.18%	11.35%	-15.69%
5	MRK Merck & Co., Inc. SPX	118.72	33.44	$293.22B	2.86%	20.66%	18.94%	3.12%	7.93%
6	TMO Thermo Fisher Scientific Inc. SPX	492.51	27.11	$183.03B	0.38%	9.17%	13.52%	-0.27%	-1.19%
7	AMGN Amgen Inc. NDXSPX	336.79	23.42	$181.77B	2.99%	18.02%	101.32%	11.77%	5.58%
8	GILD Gilead Sciences, Inc. NDXSPX	134.43	18.29	$166.90B	2.44%	22.92%	43.36%	2.57%	22.83%
9	ISRG Intuitive Surgical, Inc. NDXSPXAI	424.64	51.53	$150.39B	-	15.96%	17.23%	17.39%	29.26%

Quarterly Results

Figures in USD.

Metric	Dec 2015	Mar 2016	Jun 2016	Sep 2016	Dec 2016	Mar 2017	Jun 2017	Sep 2017	Dec 2017	Mar 2018	Jun 2018	Sep 2018	Dec 2018	Mar 2019	Jun 2019	Sep 2019	Dec 2019	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Mar 2022	Jun 2022	Sep 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	-	-	-	-	-	1.09B	1.10B	1.08B	1.09B	1.25B	1.30B	1.27B	1.26B	1.32B	1.36B	1.39B	1.37B	1.41B	1.23B	1.42B	1.46B	1.55B	1.56B	1.53B	1.60B	1.58B	1.57B	1.21B	1.21B	1.19B	1.22B	1.32B	1.28B	-	-	1.35B	1.34B	1.36B	1.40B	1.42B
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.17B	1.18B	1.22B	1.25B	1.25B
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	180.56M	155.45M	147.45M	145.83M	175.47M
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	67.82M	68.92M	74.49M	81.90M	77.05M
Operating Income	62.30M	86.89M	101.05M	56.16M	55.74M	91.77M	115.66M	72.10M	76.35M	108.60M	120.56M	99.84M	88.28M	111.72M	124.88M	122.91M	112.37M	128.68M	119.52M	156.13M	163.33M	202.01M	283.97M	150.25M	103.98M	120.97M	91.47M	151.46M	159.20M	129.96M	-	118.47M	73.86M	-	-	112.75M	86.53M	72.96M	63.94M	98.42M
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	160.06M	135.00M	120.39M	115.54M	148.09M
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	29.07M	29.98M	30.02M	28.87M	28.34M
Pretax Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	96.19M	70.17M	55.93M	50.46M	82.09M
Tax Provision	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	21.45M	12.29M	11.75M	12.72M	18.32M
Net Income	29.33M	54.83M	33.94M	6.47M	20.17M	15.87M	42.05M	18.46M	100.80M	33.74M	46.51M	32.92M	24.67M	40.83M	44.82M	30.73M	32.07M	53.12M	51.65M	76.95M	77.27M	110.55M	164.89M	76.93M	49.12M	55.21M	27.17M	70.81M	78.24M	48.18M	46.27M	96.90M	77.56M	-	-	56.68M	40.57M	28.79M	20.17M	43.99M
Diluted EPS	0.22	0.42	0.26	0.05	0.15	0.12	0.32	0.14	0.75	0.25	0.35	0.24	0.18	0.30	0.33	0.23	0.24	0.40	0.39	0.57	0.57	0.82	1.22	0.57	0.37	0.43	0.21	0.56	0.61	0.38	-	0.75	0.60	-	-	0.44	0.32	0.23	0.16	0.35

Profit & Loss (Annual)

Figures in USD.

Metric	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Revenue	-	-	-	-	-	-	-	4.22B	4.37B	5.08B	5.45B	5.53B	-	4.61B	4.83B	5.19B	5.45B
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	4.21B	4.25B	4.55B	4.82B
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	401.49M	571.61M	633.64M	629.29M
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	256.74M	304.37M	365.33M	293.12M
Operating Income	235.84M	236.14M	310.72M	336.86M	301.44M	284.48M	274.79M	299.85M	355.88M	417.28M	471.88M	567.66M	-	144.75M	267.24M	268.31M	336.17M
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	378.56M	502.63M	507.27M	530.99M
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	137.47M	154.16M	128.60M	117.94M
Pretax Income	-	-	-	-	-	-	-	-	-	-	-	-	-	35.27M	139.72M	174.77M	272.75M
Tax Provision	-	-	-	-	-	-	-	-	-	-	-	-	-	16.72M	29.25M	44.78M	58.22M
Net Income	75.28M	77.64M	107.85M	148.23M	114.39M	120.63M	130.74M	115.41M	177.18M	137.84M	148.45M	259.00M	-	158.99M	243.49M	214.04M	146.22M
Diluted EPS	0.61	0.48	0.71	1.05	0.82	0.91	0.99	0.87	1.33	1.02	1.10	1.93	-	1.23	1.91	1.66	1.16

Compounded Sales Growth

5 Years:	5.76%
1 Year:	5.00%

Compounded Profit Growth

5 Years:	-2.75%
1 Year:	-19.40%

Stock Price Performance

1 Year:	+9.86%
6 Months:	+6.83%
3 Months:	+11.11%
1 Month:	+0.45%

Balance Sheet (Annual)

Figures in USD.

Metric	Dec 2008	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Assets	-	-	2.72B	2.77B	2.76B	2.82B	2.92B	4.39B	4.92B	5.13B	5.96B	7.34B	7.66B	-	7.67B	7.69B	5.61B	5.85B
Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.27B	1.26B	1.02B	1.03B
Cash & Equivalents	64.26M	83.68M	4.37M	12.04M	40.14M	4.32M	3.35M	14.44M	99.03M	122.55M	175.18M	335.88M	577.06M	-	97.91M	52.63M	59.69M	26.52M
Inventory	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Receivables	-	-	-	-	-	-	-	-	-	-	-	-	-	-	941.31M	724.14M	821.38M	864.21M
Total Liabilities	-	-	1.91B	1.92B	2.01B	1.99B	2.14B	3.24B	3.59B	3.55B	4.27B	5.44B	6.00B	-	6.27B	6.12B	3.61B	3.82B
Current Liabilities	-	-	499.56M	383.94M	373.27M	371.52M	394.42M	729.28M	571.63M	605.40M	705.19M	914.28M	1.44B	-	1.16B	1.25B	977.65M	984.49M
Long Term Debt	-	-	1.28B	1.39B	1.46B	1.43B	1.54B	-	-	-	-	-	-	-	3.84B	3.58B	1.69B	1.80B
Total Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	5.16B	4.52B	2.70B	2.87B
Total Equity	-	-	783.88M	819.68M	717.05M	786.23M	739.51M	859.25M	815.73M	823.37M	803.04M	770.97M	1.06B	-	1.12B	1.29B	1.68B	1.71B
Shares Outstanding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	127.17M	128.37M	128.96M	124.02M

Cash Flows (Annual)

Figures in USD.

Metric	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Operating Cash Flow	165.64M	144.54M	217.13M	-	-	-	208.41M	346.60M	238.13M	494.19M	445.18M	1.03B	-	284.82M	582.06M	517.86M	346.47M
Investing Cash Flow	-77.92M	-217.00M	-54.73M	-	-	-	-1.21B	-554.32M	-192.97M	-697.14M	-316.73M	-115.35M	-	-226.34M	-268.48M	-231.01M	-216.49M
Financing Cash Flow	-68.30M	-6.85M	-154.72M	-	-	-	1.01B	292.31M	-21.65M	255.57M	32.25M	-671.54M	-	-34.89M	-327.48M	-311.17M	-163.15M
Capital Expenditure	-	-	-	-	-	-	-	-	-	-	-	-	-	-190.37M	-229.20M	-222.18M	-229.22M
Free Cash Flow	-	-	-	-	-	-	-	-	-	-	-	-	-	94.45M	352.86M	295.69M	117.24M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-	-	-	-	23.60M	-13.90M	-24.31M	-33.17M
Dividends Paid	-	-	-	210.89M	41.96M	53.37M	13.13M	-	-	-	-	-	-	-	-	-	-

Ratios (Annual)

Figures in %.

Metric	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Gross Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	8.7%	11.8%	12.2%	11.5%
Operating Margin %	-	-	-	-	-	-	-	7.1%	8.2%	8.2%	8.7%	10.3%	-	3.1%	5.5%	5.2%	6.2%
Net Margin %	-	-	-	-	-	-	-	2.7%	4.1%	2.7%	2.7%	4.7%	-	3.4%	5.0%	4.1%	2.7%
ROE %	-	9.9%	13.2%	20.7%	14.5%	16.3%	15.2%	14.1%	21.5%	17.2%	19.3%	24.4%	-	14.2%	18.9%	12.7%	8.6%
ROCE %	-	10.6%	13.0%	14.1%	12.3%	11.2%	7.5%	6.9%	7.9%	7.9%	7.3%	9.1%	-	2.2%	4.1%	5.8%	6.9%

Shareholding Pattern

Insiders

16.36%

Institutions

82.65%

Public Float

98.82%

Top Institutional Holders

#	Holder	% Held	Shares	Value
1	Blackrock Inc.	13.93%	17.26M	$284.84M
2	Vanguard Portfolio Management LLC	5.42%	6.72M	$110.94M
3	Dimensional Fund Advisors LP	4.47%	5.54M	$91.35M
4	FIL LTD	4.00%	4.96M	$81.85M
5	Vanguard Capital Management LLC	3.89%	4.82M	$79.52M
6	State Street Corporation	3.49%	4.32M	$71.28M
7	Glazer Capital LLC	3.29%	4.08M	$67.32M
8	Geode Capital Management, LLC	2.15%	2.66M	$43.92M
9	HSBC Holdings PLC	1.81%	2.25M	$37.05M
10	Goldman Sachs Group Inc	1.68%	2.08M	$34.35M

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for SEM

No recent headlines available.

SEM · Healthcare